Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Dynamics, Recent Developments, and Strategic Insights by 2031

The Europe intra-articular injection for osteoarticular infiltrations market size is projected to reach US$ 157.08 million by 2031 from US$ 97.43 million in 2023. The market is expected to register a CAGR of 6.2% during 2023–2031. The increasing number of clinical trials is expected to enhance the development of innovative products, which are likely to trend in the market during the forecast period.

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Analysis

The rising incidence of osteoarthritis and other orthopedic disorders among the aging population and advancements made in injection techniques are factors contributing to market growth. In addition, the introduction of new formulations, increased awareness about joint health and the benefits of intra-articular injection, and higher healthcare spending in Europe that allows for better access to advanced treatment options, including intra-articular injections, are likely to fuel the Europe intra-articular injection for osteoarticular infiltrations market growth in the upcoming years.

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Overview

Osteoarthritis is an inflammatory degenerative disease characterized by the deterioration of articular cartilage and underlying bone that predominantly affects the hip and knee. The increasing prevalence of osteoarthritis among the aging population, the growing need for effective treatments, and increased awareness among healthcare professionals and patients regarding the benefits of collagen injections have propelled the demand for intra-articular injections, thereby favoring the market growth. Recent advancements in hyaluronic acid injection therapy have significantly expanded growth trajectory, such as new formulations of hyaluronic acid—Durolane—sold by Nordic Medical Solutions ApS in Denmark, have improved patient outcomes and are widely adopted in clinics.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market: Strategic Insights

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market

• Market Size 2023
  US$ 97.43 Million
• Market Size 2031
  US$ 157.08 Million

Market Dynamics

GROWTH DRIVERS

• Rising Prevalence of Osteoarthritis

FUTURE TRENDS

• Advancements in Injection Techniques

OPPORTUNITIES

• Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations

Regional Overview

• Europe

Market Segmentation

Type

• Type 1 Collagen
• Hyaluronic Acid

End User

• Hospitals
• Orthopedic Clinics

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Drivers and Opportunities

Rising Prevalence of Osteoarthritis Favors Market Growth

Globally, osteoarthritis (OA) affects more than 500 million people, accounting for 7% of the world's population, including more than 10 million from France. According to the Centers for Disease Control and Prevention (CDC) report, OA represents a major cause of long-term disability. It is prevalent among athletes and people who sustain joint injury or trauma. It is also widely reported among women, accounting for 60% of the cases reported worldwide. According to the World Health Organization (WHO) report, the geriatric population is highly prone to the risk of OA. Although OA can affect anyone, the condition is most commonly observed in adults over 40 years of age. The Versus Arthritis 2024 report estimated that there were over 10 million people with OA in the UK, i.e., 5.4 million people suffering from knee OA and 3.2 million with hip OA. Additionally, according to the Osteoarthritis and Cartilage Open Journal published in 2024, there were ~5 million adults with knee OA patients in Germany, with an increasing prevalence of 7%. Thus, with the rising prevalence of OA, new therapy options such as intra-articular injections are gaining attention in Europe.

Strategic Initiatives by Market Players in Intra-Articular Injection for Osteoarticular Infiltrations

Intra-articular injection holds tremendous potential for the treatment of joint inflammation caused by injury or osteoarthritis. A few of the recent strategic initiatives by market players are mentioned below.

• In May 2024, VSY Biotechnology announced the global launch of Re-Cross by receiving “Play Sure Doping Free Certification” for its entire intra-articular HA portfolio. It is designed for pain management and the treatment of injury-related inflammatory and osteoarthritic conditions in sports medicine.
• In September 2023, KiOmed Pharma and Arsylab formed a strategic partnership for the promotion and distribution of Kiomedine one, a new class of treatment for refractory knee osteoarthritis in France. With such collaboration, KiOmed Pharma can offer a wide range of products for the treatment of osteoarthritis, thus enhancing its position in the market.
• Contura International Ltd launched a new hydrogel injection for knee osteoarthritis during the British Orthopaedic Association (BOA) Annual Congress, 21st–24th September 2021, in the UK to enable patients to regain mobility without surgery. The new hydrogel injection consists of non-biodegradable hydrogel technology—Arthrosamid.

Thus, continuous developments in intra-articular injection for osteoarticular infiltrations with increasing collaborations and partnerships are expected to present significant growth opportunities in the Europe intra-articular injection for osteoarticular infiltrations market in the coming years.

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Report Segmentation Analysis

The key segments that contributed to the derivation of the Europe intra-articular injection for osteoarticular infiltrations market analysis are type and end user.

• Based on type, the Europe intra-articular injection for osteoarticular infiltrations market is bifurcated into Type 1 collagen and hyaluronic acid. The Type 1 collagen segment has been further segmented into polymerized, hydrolyzed, and atelocollagen types. The hyaluronic acid segment held a larger market share in 2023.
• By end user, the Europe intra-articular injection for osteoarticular infiltrations market is divided into hospitals, orthopedic clinics, and others. The hospitals segment dominated the market in 2023. The orthopedic clinics segment is anticipated to register the highest CAGR during 2023–2031.

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Share Analysis by Country

The scope of the Europe intra-articular injection for osteoarticular infiltrations market report is mainly divided into Germany, the UK, France, Italy, Spain, Denmark, and the Rest of Europe. Germany held a significant share of the market in 2023. The growth of the market is driven by the growing elderly population, rising research and development activities, and advancements in intra-articular injections. Aging population has been a major contributor to the elevated demand for intra-articular injections for treating osteoarticular disorders in the country. Osteoarthritis in the lower extremities (hips and knees) causes more mobility loss than in the upper extremities. These conditions can be managed and treated with the use of knee hyaluronic acid injection treatment; thus, it has great potential for growth and provides a rewarding opportunity to the players serving in this market. In addition, the presence of various players offering intra-articular injection treatment and conducting clinical trials favors the market growth in Germany.

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Report Scope

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market News and Recent Developments

The Europe intra-articular injection for osteoarticular infiltrations market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Europe intra-articular injection for osteoarticular infiltrations market are listed below:

• Maxigen Biotech Inc. (MBI) signed an exclusive distribution agreement with Mars Medicine Sağlık Ürünleri Limited Şirketi, one of the largest distributors of pharmaceutical products in Turkey, as Maxigen Biotech’s long-term, strategic partner in opening the Turkish market. This partnership aims to provide the best intra-articular injection technology to medical institutions in Turkey by supplying MBI’s products, which offer patients a full range of knee treatment solutions. Due to Turkey’s crucial location between the Middle East and Europe, this alliance will accelerate MBI’s expansion in those markets. (Source: Maxigen Biotech Inc., Press Release, November 2022)
• Contura Orthopaedics Ltd collaborated with Horizon Lab Company, one of Italy’s leading independent medical device distributors, to promote patient access to its unique treatment—Arthrosamid—in Europe. (Source: Contura Orthopaedics Ltd, Press Release, June 2022)

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Report Coverage and Deliverables

The “Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Europe intra-articular injection for osteoarticular infiltrations market size and forecast at regional and country levels for all the key market segments covered under the scope
• Europe intra-articular injection for osteoarticular infiltrations market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Europe intra-articular injection for osteoarticular infiltrations market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Europe intra-articular injection for osteoarticular infiltrations market
• Detailed company profiles